Advertisement
  • Loading metrics

When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa

  • Michael Schomaker ,

    Michael.schomaker@uct.ac.za

    Affiliation Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa

  • Matthias Egger,

    Affiliation Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

  • James Ndirangu,

    Affiliation Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa

  • Sam Phiri,

    Affiliations Lighthouse Trust Clinic, Kamuzu Central Hospital, Lilongwe, Malawi, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

  • Harry Moultrie,

    Affiliations Wits Reproductive Health and HIV Institute, Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, Soweto, South Africa, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa

  • Karl Technau,

    Affiliation Empilweni Service and Research Unit, Rahima Moosa Mother and Child Hospital and University of Witwatersrand, Johannesburg, South Africa

  • Vivian Cox,

    Affiliations Médecins Sans Frontières South Africa, Cape Town, South Africa, Khayelitsha ART Programme, Khayelitsha, Cape Town, South Africa

  • Janet Giddy,

    Affiliation Sinikithemba Clinic, McCord Hospital, Durban, South Africa

  • Cleophas Chimbetete,

    Affiliation Newlands Clinic, Harare, Zimbabwe

  • Robin Wood,

    Affiliations Desmond Tutu HIV Centre, Cape Town, South Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa

  • Thomas Gsponer,

    Affiliation Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

  • Carolyn Bolton Moore,

    Affiliations University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia

  • Helena Rabie,

    Affiliation Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa

  • Brian Eley,

    Affiliation School of Child and Adolescent Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa

  • Lulu Muhe,

    Affiliation Department of Maternal, Child and Adolescent Health, World Health Organization, Geneva, Switzerland

  • Martina Penazzato,

    Affiliations Department of Maternal, Child and Adolescent Health, World Health Organization, Geneva, Switzerland, Clinical Trial Unit, Medical Research Council, London, United Kingdom

  • Shaffiq Essajee,

    Affiliation Clinton Health Access Initiative, Boston, Massachusetts, United States of America

  • Olivia Keiser,

    Affiliation Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

  • Mary-Ann Davies,

    Affiliation Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa

  •  [ ... ],
  • for the International Epidemiologic Databases to Evaluate AIDS–Southern Africa (IeDEA-SA) Collaboration
  • [ view all ]
  • [ view less ]

When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa

  • Michael Schomaker, 
  • Matthias Egger, 
  • James Ndirangu, 
  • Sam Phiri, 
  • Harry Moultrie, 
  • Karl Technau, 
  • Vivian Cox, 
  • Janet Giddy, 
  • Cleophas Chimbetete, 
  • Robin Wood
PLOS
x

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.